JP2002525081A - 低酸素により調節される遺伝子転写に特徴的な配列 - Google Patents

低酸素により調節される遺伝子転写に特徴的な配列

Info

Publication number
JP2002525081A
JP2002525081A JP2000571058A JP2000571058A JP2002525081A JP 2002525081 A JP2002525081 A JP 2002525081A JP 2000571058 A JP2000571058 A JP 2000571058A JP 2000571058 A JP2000571058 A JP 2000571058A JP 2002525081 A JP2002525081 A JP 2002525081A
Authority
JP
Japan
Prior art keywords
hypoxia
gene
seq
sequence
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000571058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002525081A5 (ru
Inventor
エイナート，パズ
スカリター，ラミ
ファインシュタイン，エレーナ
Original Assignee
クォーク・バイオテク・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クォーク・バイオテク・インコーポレーテッド filed Critical クォーク・バイオテク・インコーポレーテッド
Publication of JP2002525081A publication Critical patent/JP2002525081A/ja
Publication of JP2002525081A5 publication Critical patent/JP2002525081A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000571058A 1998-08-27 1999-08-27 低酸素により調節される遺伝子転写に特徴的な配列 Pending JP2002525081A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9815898P 1998-08-27 1998-08-27
US60/098,158 1998-08-27
US13268499P 1999-05-05 1999-05-05
US60/132,684 1999-05-05
PCT/US1999/020394 WO2000012525A1 (en) 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription

Publications (2)

Publication Number Publication Date
JP2002525081A true JP2002525081A (ja) 2002-08-13
JP2002525081A5 JP2002525081A5 (ru) 2006-10-12

Family

ID=26794273

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000571058A Pending JP2002525081A (ja) 1998-08-27 1999-08-27 低酸素により調節される遺伝子転写に特徴的な配列
JP2000567249A Pending JP2002523072A (ja) 1998-08-27 1999-08-27 低酸素症調節遺伝子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2000567249A Pending JP2002523072A (ja) 1998-08-27 1999-08-27 低酸素症調節遺伝子

Country Status (6)

Country Link
EP (2) EP1115733A4 (ru)
JP (2) JP2002525081A (ru)
AU (1) AU5810999A (ru)
CA (2) CA2341705A1 (ru)
IL (2) IL141660A0 (ru)
WO (2) WO2000012139A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013220090A (ja) * 2012-04-19 2013-10-28 Tohoku Univ 眼疾患治療に使用する薬剤スクリーニング方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． 電気的筋肉制御装置
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
EP1343912A2 (en) * 2000-11-28 2003-09-17 Wyeth Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
DE60237406D1 (de) * 2001-05-31 2010-09-30 Chiba Prefecture Aus einem Neuroblastom isolierte Nukleinsäuren
AU2002324451A1 (en) * 2001-06-21 2003-01-08 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
AU2003284357A1 (en) * 2002-11-01 2004-06-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
EP1670425A4 (en) * 2003-10-07 2008-04-16 Quark Pharmaceuticals Inc BONE MORPHOGENETIC PROTEIN (BMP) 2A AND ITS APPLICATIONS
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
JP2011206049A (ja) * 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
AU2017368050A1 (en) 2016-11-29 2019-06-20 Puretech Lyt, Inc. Exosomes for delivery of therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000353A1 (en) 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product
US5731294A (en) * 1993-07-27 1998-03-24 Hybridon, Inc. Inhibition of neovasularization using VEGF-specific oligonucleotides
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013220090A (ja) * 2012-04-19 2013-10-28 Tohoku Univ 眼疾患治療に使用する薬剤スクリーニング方法

Also Published As

Publication number Publication date
EP1107797A2 (en) 2001-06-20
CA2341518A1 (en) 2000-03-09
EP1107797A4 (en) 2002-10-16
WO2000012139B1 (en) 2000-05-04
EP1115733A4 (en) 2003-01-22
IL141666A0 (en) 2002-03-10
WO2000012525A1 (en) 2000-03-09
EP1115733A1 (en) 2001-07-18
JP2002523072A (ja) 2002-07-30
AU5810999A (en) 2000-03-21
WO2000012139A1 (en) 2000-03-09
CA2341705A1 (en) 2000-03-09
IL141660A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
US6740523B2 (en) 14-3-3σ arrests the cell cycle
EP1009753B1 (en) Hypoxia-regulated genes
US7524935B2 (en) Sequences characteristic of hypoxia-regulated gene transcription
JP2002525081A (ja) 低酸素により調節される遺伝子転写に特徴的な配列
US20100311161A1 (en) Method for tissue regeneration
JP2009213490A (ja) 骨及び／又は関節疾患関連遺伝子
US6545139B1 (en) DNA sequence encoding the p99 gene and kits for the detection of neoplasia
JP2003510349A (ja) 線条体機能に必要な遺伝子、その使用、およびそれを調節するための化合物
JP2003512304A (ja) 医薬組成物および分泌フリズル化関連タンパクを用いる方法
US20030104973A1 (en) Hypoxia-regulated genes
US7973156B2 (en) Hypoxia-regulated genes
US20050004065A1 (en) Hypoxia regulated genes
JP2007523608A (ja) サイクリックａｍｐ応答エレメントアクティベータータンパク質およびそれに関連する使用
JP4723133B2 (ja) 新規ヒトｂｍｃｃ１遺伝子
WO2000034466A1 (en) Cervical cancer treatment
ZA200101566B (en) Sequences characteristic of hypoxia-regulated gene transcription.
JPWO2003070951A1 (ja) 動脈硬化特異的遺伝子とその利用
WO2002092840A2 (en) Agents that regulate apoptosis
AU2002328200B2 (en) DNA sequences for human angiogenesis genes
US20040038247A1 (en) Nucleic acid constructs including a novel t-cell active promoters, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response
JP2001025389A (ja) Ｔｓａ７００５遺伝子
JP2000507099A (ja) 平滑筋細胞ｌｉｍ蛋白質
WO2001079467A2 (en) Identification of a renal nadph oxidase

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060817

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060817

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090728

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091110